Abstract: Background: Despite major advances, the treatment of sepsis is still a challenging problem for surgeons. This study was aimed to compare the therapeutic effects of methylprednisolone and tri-iodothyronine replacement therapy during an early sepsis. Material and methods: Forty male Wistar albino rats weighing 300-340g were divided into the Control, CLP, CLP/MP, CLP/T3 and CLP/MP/T3 groups. The Control group underwent a sham operation. Only cecal ligation and puncture was performed in the CLP group. The CLP/MP groups received an intramuscular injection of (MP) methylprednisolone (30 mg/kg) at one and half hour before CLP. The CLP/T3 group was given an intraperitoneal (IP) injection of tyroid hormone (T3) 0.4 μg/100 g immediately after CLP. The CLP/MP/T3 group was given IM injection of MP 30 mg/kg before CLP and IP injection of T3 0.4 μg/100 g after CLP. Hemavet changes, blood cultures, peritoneal bacteria content, hormonal alterations and histopathologic changes of intestinal, lung and liver tissue were used to asses the possible therapeutic effects of MP and T3 during early sepsis. Results: A septic insult resulted in signifi cant alterations on hemavet values, free T3, free T4 and cortisol levels, peritoneal bacteria content and intestinal lung and liver tissue samples of the CLP group. Hemavet changes and peritoneal infl ammation fi ndings were signifi cantly limited in the CLP/T3 and CLP/MP/T3 groups. Histopathologic changes had no signifi cant difference between the groups during an early sepsis. Conclusion: Compared to the MP replacement therapy, therapeutic effects of T3 replacement therapy have been found signifi cantly more promising (Tab. 1, Fig. 10, Ref. 49 Despite advances in systemic antibiotics and aggressive surgical intervention, septic shock and multiorgan failure resulting from sepsis continue to be the most common cause of death in surgical intensive care units. Over the past 20 years a large number of clinical trials in septic patients have been performed. In these trials, a variety of therapeutic agents for sepsis have been evaluated, based largely on progress in the understanding of the pathophysiology of sepsis (1-3).
Despite advances in systemic antibiotics and aggressive surgical intervention, septic shock and multiorgan failure resulting from sepsis continue to be the most common cause of death in surgical intensive care units. Over the past 20 years a large number of clinical trials in septic patients have been performed. In these trials, a variety of therapeutic agents for sepsis have been evaluated, based largely on progress in the understanding of the pathophysiology of sepsis (1) (2) (3) .
The use of corticosteroids has undergone a re-evaluation after the recognition of the adrenal insuffi ciency in septic patients. Recent reports in literature suggest that the treatment of specifi c populations of septic patients with corticosteroid supplementation provide a survival advantage in critically ill patients (4) (5) (6) (7) .
There is also a vast literature on the changes in thyroid function tests that occur during non-thyroidal illness such as sepsis. The changes are defi ned as a decreased concentration of plasma tri-iodotyronine with normal or low thyroxine. Therapy with thyroid hormone as either thyroxine or tri-iodothyronine has been suggested for patients with sepsis, cardiac disease, pulmonary disease or severe infection (8) (9) (10) (11) (12) .
This study aimed to evaluation and comparison of the effects of methylprednisolone and tri-iodthyronine replacement therapy during an early sepsis.
Methods

Experimental model of polymicrobial sepsis
The experiments described herein conform to the NIH Guidelines for the Care of Laboratory Animals and were approved by the ethic committee. Adult male Wistar Albino rats (300-340g) were fasted overnight before the induction of sepsis but allowed water and libitum. The rats were anesthetized with an intramuscular injection of ketamin (50 mg/kg) and xylazine (5 mg/kg) and randomized to fi ve groups including the control, cecal ligation and puncture (CLP), CLP with methylprednisolone treatment (CLP/ /MP), CLP with tri-iodothyronine treatment (CLP/T3) and CLP with methylprednisolone and tri-iodothyronine combined treatment (CLP/MP/T3). There were eight animals in each group. Wichterman (13) model was performed as a CLP model. A 2-cm midline incision was made and the cecum was ligated with 4/0 silk just distal to the ilececal valve to avoid intestinal obstruction. The cecum was punctured twice with a 18-gauge needle on the antimesenteric side and the bowel was gently squeezed to extrude a small amount of fecal material and returned to abdominal cavity. The control groups underwent a sham laparatomy. The treatment group (CLP/MP) received an intramuscular injection of methylprednisolone (30 mg/kg Prednol®, Mustafa Nevzat Turkey) at one and half hour preoperatively. The treatment group (CLP/T3) received an intraperitoneal injection of tyroid hormone (0.4 μg/100 g Thyrotardin® Inject N Henning Berlin GMBH Germany) immediately after CLP. The combined treatment group (CLP/MP/T3) received an intramuscular injection of methylprednisolone (30 mg/ kg Prednol®, Mustafa Nevzat) at one and half hour preoperatively and an intraperitoneal injection of tyroid hormone (0.4 μg/100g Thyrotardin® Inject N Henning Berlin GMBH Germany) immediately after CLP. The abdominal incision was closed in two layers.
Immediately after surgery, each rat received a subcutaneous injection of 1ml saline and an intramuscular injection of İmipenem (15 mg/kg). The rats were put into cages until postopeative sixth hour. At sixth hour after CLP or sham operation the animals were anesthetized again with an intramuscular injection of ketamin (50 mg/kg) and xylazine (5 mg/kg)
Evaluation of Peritoneal Infl ammation and Peritoneal Bacteria Content
At the end of sixth hour a re-laparatomy was performed on all rats and the degree of peritoneal infl ammation was assessed according to Simon's (14) method (Tab. 1). Later, peritoneal lavage was performed with 4ml of normal saline. Next 50 μl of this fl uid was incubated in blood agar and Mc Conkey's agar at 37 ºC for 24 hours. Peritoneal bacteria content was evaluated and described as colony forming units per mililiter (CFU/ml).
Determination of hemavet changes and hormon levels
Blood samples were obtained by intracardiac puncture, some of these samples were analyzed by automated (Beckman-Coulter T-890®) differential cell counting immediately following a specimen collection. Some of intracardiac blood samples were used to determine serum freeT3, freeT4 and cortisol hormon levels. Thyroid hormone levels were measured by using Architecht free T3 or Architecht free T4 kits in Architecht I-2000® analyzer, cortisol levels were measured by using Elecsys Cortisol CalSet (Roche® diagnostics Gmbh) kits in Elecsys2010® analyzer.
Preparation and evaluation of blood cultures
A 1 ml sample of blood from each animal was immediately placed into a biphasic blood culture medium containing Brain Hearth Infusion (BHI) broth and BHI agar and incubated at 37 ºC for 18-24 hours under aerobic conditions. After incubation from all culture materials, subsequent subcultures were performed on blood agar and Mc Conkey agar. All subcultures were incubated under aereobic conditions and were examined at18-24 hour for presence of growth. The identifi cation of bacterial species was performed by standard microbiological methods.
Determination of histopathologic changes
During scarifi cation, terminal ileum, left hepatic lobe and left lung lobe tissue samples were removed from each animal for determination of histopathologic changes. Paraffi n sections were stained with hematoxylin and eosin stain. Pathologist examined all specimens in a blinded fashion. The tissue sections were observed and photographed on a research microscope for each experimental animal.
Statistical analysis
Data analysis was performed using a statistical software program, SPSS for Windows.11.0. Kruskal-Wallis, Mann-Whitney-U and one-way analysis of variance (Tukey post hoc) tests were employed and the differences were considered signifi cant at p value < 0.05.
Results
Intraperitoneal macroscopic fi ndings were assessed as Grade 0 in the control animals whereas Grade III and IV intraperitoneal infl ammatory alterations were recorded in CLP animals (25 % and 75 % respectively). Grade III (75 %) and grade IV (25 %) intraperitoneal infl ammation fi ndings were also observed in CLP/MP treatment groups. CLP/T3 and CLP/MP/T3 treatment groups had no grade IV intraperitoneal infl ammation fi ndings. Intraperitoneal infl ammatory alterations were signifi cantly limited in CLP/T3 and CLP/MP/T3 treated rats compared to septic (CLP) and metylprednisolon treated (CLP/MP) animals (p<0.05 and p<0.007 respectively). There was no signifi cant difference between the CLP/T3 and CLP/MP/T3 animals regarding intraperitoneal infl ammatory alterations.
The peritoneal bacteria contents of the study groups are detailed in Fig. 1 . As compared to the control group, the bacterial Grade 0 No Infl ammation Grade I Well walled off abscess, no free peritoneal fl uid Grade II Walled-off abscess, small amount of free peritneal fl uid and patchy areas of cecal wall necrosis. Grade III Poor localization of the infl ammatory proces, moderate amount of free peritoneal fl uid and gangrenous cecum. Grade IV No walling off of the cecum, large amount of free hemorrhagic fl uid in the peritoneal cavity, and extensive gangrene and hemorrhagic fl uid in the cecal wall. contents of the peritoneal lavages of CLP and the other groups were found signifi cantly increased at six hours after CLP. There was no statistically signifi cant difference in the bacterial contents of peritoneal lavages of these groups. Blood cultures of all control animals were negative. Blood cultures were found positive in three (40 %) of CLP group animals, one (25 %) of CLP/MP treated animals, 4 (50 %) of CLP/T3 treated animals and in 4 (50 %) of CLP/MP/T3 treated animals. As shown in Figure 2 , septic insult resulted in a signifi cantly decreased white blood cell (WBC) count in CLP (0.59x10 /μl) treated animals compared to levels in septic (CLP) animals (p=0.047 and p=0.013 respectively). White Blood Cell counts had no signifi cant differences between the CLP/T3 and CLP/MP/T3 treated animals.
Hemoglobin values were found signifi cantly low in septic (1.87 g/dl) and CLP/MP (1.88 g/dl) animals compared to the values ((2.65 g/dl) of control animals (p=0.004 and p=0.005 respectively). In contrast, the hemoglobin values of CLP/T3 (2.63 g/dl) and CLP/MP/T3 (2.92 g/dl) treated animals were signifi cantly (p=0.005 and p=0.001 respectively) higher than the values of CLP animals. Additionally, hemoglobin values of CLP/T3 treated animals were also signifi cantly (p=0.006) higher than those of CLP/ MP treated animals (Fig. 3) .
The platelet counts of the groups are shown in the Fig. 4 . There was a signifi cant decrease in the platelet count in CLP (53.60x10 The mean serum free T3 (FT3) concentrations in CLP group(1.02 pg/ml) were decreased signifi cantly (p=0.004) compared to control rats (1.62 pg/ml) at six hours. As compared to the septic (CLP) group, the mean serum FT3 concentrations were signifi cantly high in both CLP/T3 (13.33 pg/ml) and CLP/MP/T3 (7.43 pg/ml) treated groups (p<0.001 and p<0.001 respectively). The mean serum FT3 concentrations are detailed in the Fig. 5 .
The mean serum free T4 (FT4) concentrations are shown in Fig. 6 . There were no differences between the serum FT4 levels of CLP group and those of control groups. CLP/MP treated animals had signifi cantly low serum FT4 concentrations compared to the CLP and control animals (p<0.001 and p=0.009 respectively). The mean serum cortisol levels were similar in the control (2.86 μg/dl), CLP (2.93 μg/dl) and CLP/T3 (2.73 μg/dl) treated animals. Metylpredisolon replacement treatment resulted in markedly elevated serum cortisol levels in CLP/MP (36.67 μg/dl) and CLP/MP/T3 (26.08 μg/dl) treated groups as expected (Fig. 7) .
Intestinal tissue architecture was well preserved in control animals (Fig. 8a) . Villous pattern showed some alterations in the other groups. Necrosis of villous tip was noted in one of CLP animals, 2 (25 %) of CLP/MP treated animals, one of CLP/T3 treated animals and in 2 (25 %) of CLP/MP/T3 treated animals (Fig. 8b) . CLP, CLP/MP, CLP/T3 and CLP/MP/T3 treated animals had no signifi cant difference regarding to the infi ltration of the infl ammatory cells and the edema of the villi at six hour after CLP.
There was a severe congestion of the liver in all group animals. Portal infl ammatory cell infi ltration in liver tissues were observed in CLP, CLP/T3 and CLP/MP/T3 group animals (Fig. 9a) . CLP/ MP treated animals have signifi cantly limited portal infl ammatory cell infi ltration (Fig. 9b) . The histopathologic alterations in liver tissue had no signifi cant difference between the groups.
CLP resulted in distinct congestion, alveolar edema and some emphysematous changes during early sepsis (Fig. 10) . Animals in CLP and other treatment groups had no signifi cant difference regarding to histopatologic alterations in lung tissue samples. 
Discussion
Despite the advances in critical medicine, the management of the patients with severe sepsis is usually supportive rather than therapeutic. The failure of clinical trials with promising immunomodulatory agents seems to be related with the fl awed or inappropriate animal models. Animal studies also failed to reproduce the cardiopulmonary and metabolic responses seen in clinical practice. The confi rmation of the effi cacy of potential therapeutic agents from simple animal studies to clinical trials comprises another challenging problem. Therefore the more realistic animal models are a prerequist for the more comparable results (1, 3) .
In this study, we performed CLP experimental polymicrobial sepsis model because it resembles the clinical situation of bowel perforation, inducing peritonitis due to mixed intestinal fl ora (15) . In this model, initial hyperdynamic phase is characterized by an increased cardiac output, tissue perfusion and decreased total peripheral resistance. This is followed by late, hypodynamic phase, characterized by reduced cardiac output and microvascular blood fl ow in various tissues (16) . Our study scopes and compares the hematologic, hormonal and histopathologic alterations during early hyperdynamic phase.
Hiramatsu et al showed infl ammatory changes in the cecum at 3 h and the collection of purulent peritoneal fl uid within 12 h following CLP with a 25 gauge needle (17) . In our study, signifi cant infl ammatory changes were established in the cecum with purulent peritoneal fl uid collection in CLP group animals at 6 h after CLP with a 18 gauge needle. Both blood cultures and peritoneal lavage cultures defi ned the nature of the infl ammation as polymicrobial sepsis in the CLP treated animals.
It has been suggested that sepsis is characterized by leucocytosis or leucopenia, isolated thrombocytopenia, and decreased hemoglobin values, however there is no specifi c laboratory dependent criteria for diagnosis (18) . Particularly thrombocytopenia may be an early indicator of gram-negative sepsis in pediatric and burned patients (19) . In our study, signifi cant leukopenia, thrombocytopenia and decreased hemoglobin values were noted in CLP group animals at 6 h after CLP. The hematologic changes were consistent with those observed in animals with polymicrobial sepsis of the previous experimental studies.
Previous trials have clearly demonstrated that sepsis activates the Hypothalamic-Pituitary-Adrenal axis to release corticotropin and glucocorticoid hormones (20, 21) . Cortisol plays a vital supportive role in the maintenance of vascular tone, endothelial integrity, vascular permeability and the distribution of total body water within the vascular compartment and also enhances the vasoconstrictor actions of catecholamines. It has been shown that an increase in the half-life of cortisol occured during septic shock whereas adrenalectomy reduced the tolerance of animals to experimentally induced septic shock. It is obvious that normal adrenal gland function and increased plasma cortisol levels are important and necessary for the protection of homeostatic response (22) (23) (24) . Although control and CLP animals have no signifi cant differences in plasma cortisol levels at 6h after CLP, we measured markedly decreased plasma cortisol levels in the CLP group animals at 48 h after CLP in our second part of study.
Sepsis also infl uences the hypothalamic pituitary thyroid axis by decreasing the circulating levels of T3. This functional hypothyroidism is characterized by a low serum T3 level, a normal or low serum T4 level and normal TSH level. This syndrome is collectively referred to as euthyroid sick syndrome. Previous studies showed that intact thyroid functions are essential for survival from shock and T3 supplementation improves mortality rates in hypothyroid animals. The degree of decreasing levels of T3 is closely related to prognosis (25) (26) (27) . Our study showed that CLP resulted in signifi cantly decreased T3 levels at 6h after CLP. The animals receiving T3 treatment exhibited more improved hematologic parameters and signifi cantly limited intraperitoneal infl ammation fi ndings. The improvements in hematologic parameters and limitation of intraperitoneal infl ammation fi ndings in T3 treated animals are explained by preservation of cellular and humoral immunity. Previous experimental studies demonstrated that surgically or chemically induced thyroid hormone depletion resulted in significantly decreased cellular and humoral immunity. Conversely, thyroid hormone repletion enhances both types of immunity (28, 29) .
Though, there is still considerable controversy concerning the use of corticosteroids in the treatment of severe sepsis. Corticosteroids have antinfl ammatory and immunosupressive effects and also inhibit the synthesis of IL-1, IL-6, IL-8 and TNF-α. Bone et al reported that corticosteroids had benefi cial effects when they had been administered before or as early as possible after the insult. Low-dose glucocorticoids exerted their positive effects by means of stabilization of lysosomal and cell membranes, inhibition of complement-induced granulocyte aggregation, improved myocardial performance and improvement in metabolic defects. Low-dose glucocorticoids also reduced the requirement of vazopressors in management of septic shock (30) (31) (32) . The data from this study failed to demonstrate that corticosteroid replacement therapy had an effect on the improvement of hemavet changes and limitation of peritoneal infl ammation during early experimental sepsis. However, the platelet counts have been noted slightly high in this replacement group when compared to the septic group animals.
Reports are found in literature that activation of coagulation occurs in experimental sepsis models. Activation of clotting and fi brinolytic pathways resulted in the consumption of platelets and coagulation factor concentrations. Antithrombin III (ATIII) inhibits the clotting cascade and also reduces the infl ammatory response (33-37). Chapital et al. reported that T3 supplementation reduced the sepsis-induced decrease in ATIII levels (28) . Our data showed that T3 administration signifi cantly increased the platelet counts and limited the intraperitoneal infl ammatory changes.
In our study, the spectrum of bacteria isolated from blood and peritoneal lavage cultures were in line with the previous reports. In the current study, the metabolic and histopathologic alterations were not parallel with the results of blood or peritoneal lavage cultures. However, there was no signifi cant difference in bacteria content of the blood and peritoneal lavage of the CLP treated and replacement groups (31, 38) . These fi ndings were found compatible with the thesis of 'The development of shock was not related o the presence or absence of a positive blood culture'.
Pulmonary dysfunction is the end organ response of the lung to a septic insult and defi ned as adult respiratory distress syndrome (ARDS). A variety of pathophysiologic mechanisms have been shown to play a role in the pathogenesis of ARDS. Salkowski et al. showed dramatic increases in lung proinfl ammatory and antiinfl ammatory cytokines and chemokines during the early phase of polymicrobial sepsis. Schwartz et al. reported that the activation of nuclear factor κB (NFκB) in alveolar macrophages is an important step in the pathophysiology of ARDS. It is also known that a decrease in lung compliance and alterations in type-2 cellular function occur during sepsis. Infl ammatory cell activation and, in particular neutrophil activation, also plays an important role in the pathogenesis of sepsis-induced ARDS (39) (40) (41) . In the current study, CLP induced polymicrobial sepsis caused a widespread alveolar edema and congestion at 6h after CLP. Histologic examinations of the lungs of the T3 treated animals exhibited minimal alveolar edema. Many authors have examined the effects of T3 administration on pulmonary function in sepsis. Improvement in respiratory drive, pulmonary histologic integrity and surfactant availability have been found in this trials (42, 43) . The mechanism for this improvement could be attributed to the maintenance of type-2 cellular function and diminishing the infl ammatory response by preservation of ATIII levels. There was no signifi cant improvement in sepsis induced histopathologic alterations in the lungs of the rats receiving MP treatment during an early phase of the polymicrobial sepsis.
Chaudry et al demonstrated that hepatocellular dysfunction occured during the very early stage of polymicrobial sepsis. The Kupffer cells derived proinfl ammatory cytokines IL-1β and IL-6 appeared to be directly or indirectly responsible for producing hepatocellular dysfunction during early sepsis (44, 45) . In this study, CLP resulted in markedly histopathologic changes defi ned as congestion, dilatation of the portal sinusoids and infi ltration of the infl ammatory cells during early sepsis. Histologic evaluation of the liver tissues of the MP-treated animals revealed a preservation of normal architecture of the sinusoids and minimal congestion. This improvement in hepatocellular tissue in MP-treated animals could be explained by decreasing IL-1β and IL-6 synthesis. Gloor et al demonstrated that glucocorticoids blocked IL-1β and IL-6 synthesis by interfering with the transcription of the cytokine gene (46) .
Our study showed that the animals receiving T3 treatment also exhibited a well preserved liver tissue architecture at 6 hours after CLP. When we compared the protective effects of T3 and MP on CLP-induced histopathologic alterations in the liver, T3 replacement therapy seemed to be more protective regarding the congestion of liver. Histologic examination of the livers of the MP treated animals exhibited a signifi cantly decreased infi ltration of infl ammatory cells in portal sinusoids. Nagaya et al. reported that activation of NFκB played an important role in immune and infl ammatory responses by controlling gene expression of several cytokines. The activation of NFκB byTNF-α may be responsible for pathogenesis of euthyroid sick syndrome (47) .
Previous experimental studies showed that the intestinal tissue seemed to be more vulnerable during the late stage of sepsis. CLP induced sepsis caused minimal intestinal histopathologic changes during early period in this study. Yang et al showed marked intestinal histopathologic changes at 21 h after CLP (48, 49) . We had no signifi cant histopathologic alterations in the intestinal tissues of the rats given replacement therapy or CLP treated.
In this study, the rats administered MP and T3 combined replacement therapy had signifi cantly higher serum T3 levels whereas the serum T4 levels were normal. As compared to the T3 replacement group, serum T3 levels were found slightly lower in the rats receiving MP/T3 combined replacement therapy. These fi ndings could be attributed to a decreased conversion of T4 to T3 in the presence of cortisol. Although it had no superiority regarding only T3 replacement therapy, combined MP/T3 hormone replacement therapy caused signifi cant improvements in CLP induced hemogram changes and histopathologic alterations.
Conclusion
In conclusion, this study showed that CLP induced polymicrobial sepsis resulted in hemogram changes, histopatologic alterations in liver and lung tissues and also hormonal changes defi ned as euthyroid sick syndrome. We suggest that both T3 replacement therapy and MP/T3 combined replacement therapy have signifi cant protective and healing effects on the hematologic and histopathologic derangements which occur during early polymicrobial sepsis. The infl ammatory response can be controlled and effectively limited by using T3 replacement therapy during an early sepsis.
